| Alexandra Schulsinger, | |
|
30 Prospect Ave, Hackensack, NJ 07601-1915 | |
| (551) 996-2000 | |
| Not Available |
| Full Name | Alexandra Schulsinger |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 30 Prospect Ave, Hackensack, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003513037 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 310875 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alexandra Schulsinger, 170 Lafayette St Apt T01, Jersey City, NJ 07304-4614 Ph: (201) 566-3409 | Alexandra Schulsinger, 30 Prospect Ave, Hackensack, NJ 07601-1915 Ph: (551) 996-2000 |
News Archive
Potential new treatments for Parkinson's disease developed by researchers at Rush University Medical Center have shown success in slowing progression of the disease in mice.
Case Western Reserve University (CWRU) School of Medicine has received $7,942,500 million in federal stimulus funds from the Ohio Health Information Partnership (OHIP), the state designated entity for health information exchange development. The funding will position CWRU School of Medicine as a regional extension center (REC) which allows it to help 1,765 health care providers in Lorain, Cuyahoga, Lake, Geauga and Ashtabula counties advance the use of health information technology (HIT) in their practices.
Children on the high-fat ketogenic diet to control epileptic seizures can prevent the excruciatingly painful kidney stones that the diet can sometimes cause if they take a daily supplement of potassium citrate the day they start the diet, according to research from Johns Hopkins Children's Center.
Boston Scientific Corporation today announced the completion of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of the Company's fourth-generation SYNERGY™ Coronary Stent. The randomized, single-blind, non-inferiority trial will compare the SYNERGY Stent to the PROMUS Element™ Everolimus-Eluting Coronary Stent in patients with a single de novo native coronary artery lesion.
› Verified 7 days ago
Mrs. Lauren Anne Carucci, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 551-996-2000 | |
Michael Anthony Williams-healy, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 155 Polifly Rd, Hackensack, NJ 07601 Phone: 201-343-6360 | |
Ms. Elizabth Anne Bilotti, APN-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 20 Prospect Ave, The Cancer Center At Hackensack University Medical Ctr., Hackensack, NJ 07601 Phone: 201-996-5900 | |
Mrs. Katherine Elizabth Demarco, APN-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect Avenue, Humc, Pain & Palliative Medicine Institute, Hackensack, NJ 07601 Phone: 201-996-2000 | |
Stephanie Akanbi, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 551-996-2576 | |
Irene Krawczyk, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 551-996-2000 |